Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Invasive Breast Cancer × pertuzumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 29 HER2-positive Breast Cancer 2 Brain Neoplasms 2 Solid Tumors 1 Solid Cancer 1 Neoplasm Metastasis 1 Metastatic Breast Cancer With a Isolated Brain Progression 1 Malignant Solid Neoplasm 1 Invasive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 Endometrial Neoplasms 1 Breast Diseases 1 Breast Cancer Invasive 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1 Advanced HER2+Breast Cancer 1

Interventions

Surgical Procedures, Operative 2 Paclitaxel 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 pertuzumab 1 liposomal doxorubicin 1 cemiplimab 1 atezolizumab 1 Trastuzumab 1 Radiotherapy 1 Indocyanine Green 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03595592 2024-03-06

APTneo

Fondazione Michelangelo

Phase 3 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡